Yuhan Corporation acquires ‘Sovaldi’ & ‘Harvoni’ license worth of KRW 120 billion a year

Published: 2017-07-07 16:27:00
Updated: 2017-07-07 14:12:10

In the official notice on the 5th, Yuhan Corporation announced it signed an exclusive sales agreement of ‘Sovaldi’ and ‘Harvoni,’ hepatitis C treatments, in Korea with U.S. Gilead.

Gilead’s ‘Sovaldi’ and ‘Harvoni’ sales in Korea were approximately KRW 120 billion in 2016.

Yuhan Corporation expl...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.